Miguel Gaspar

Company: AstraZeneca

Job title: Senior Director Oncology Research and Development

Seminars:

Showcasing Claudin18.2 T Cell Engager for GC & PDAC Malignancies 10:30 am

Reviewing CLDN18.2 expression as a target for GC and PDAC tumours Strategies for increasing the therapeutic index of T cell engagers and application to CLDN18.2 Preclinical data on AZD5863 – a clinical stage CLDN18.2 T cell engagerRead more

day: Conference Day 2